Metformin reduces mitochondrial ROS levels and improves mitochondrial mass, membrane potential and respiratory complexes in leukocytes of type 2 diabetic subjects
Por:
de Maranon, A, Diaz-Pozo, P, Canet, F, Vezza, T, Abad-Jimenez, Z, Lopez-Domenech, S, Falcon, R, Banuls, C, Rocha, M and Victor, V
Publicada:
1 mar 2021
Ahead of Print:
1 mar 2021
Resumen:
Filiaciones:
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
:
Univ Hosp Doctor Peset FISABIO, Dept Endocrinol & Nutr, Valencia, Spain
Univ Valencia, Dept Physiol, Valencia, Spain
|